Cargando…

Acquired amegakaryocytic thrombocytopenia after durvalumab administration

Immune checkpoint inhibitors (ICIs), despite their ability to potentiate antitumor T-cell responses, may cause various immune-related adverse events. Most cases of thrombocytopenia induced by ICIs have revealed a pathophysiologic mechanism of immune thrombocytopenia with increased platelet destructi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suyama, Takahiro, Hagihara, Masao, Kubota, Naoto, Osamura, Yoshiyuki, Shinka, Yoko, Miyao, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JSLRT 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053569/ https://www.ncbi.nlm.nih.gov/pubmed/33431742 http://dx.doi.org/10.3960/jslrt.20047

Ejemplares similares

Mononeuritis multiplex in acquired amegakaryocytic thrombocytopenia
por: Khan, Firosh, et al.
Publicado: (2015)

Acquired Amegakaryocytic Thrombocytopenia Associated With Autoimmune Hemolytic Anemia
por: Ikeda, Naoto, et al.
Publicado: (2022)

“Almost Bleeding to Death”: The Conundrum of Acquired Amegakaryocytic Thrombocytopenia
por: Brown, Gabrielle Elena, et al.
Publicado: (2014)

Acquired Amegakaryocytic Thrombocytopenia Progressing to Aplastic Anaemia
por: Hussain, Syed Ather, et al.
Publicado: (2022)

Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia in Thymoma
por: Dahal, Sumit, et al.
Publicado: (2018)

Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia
por: Nishino, Shogo, et al.
Publicado: (2018)

Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia
por: Suyama, Takahiro, et al.
Publicado: (2023)

Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine
por: Ichikawa, Takanori, et al.
Publicado: (2019)

Invasive Thymoma with Pure Red Cell Aplasia and Amegakaryocytic Thrombocytopenia
por: Onuki, Takuya, et al.
Publicado: (2016)

Transient atelectasis due to hilar lymph node swelling affected by lenalidomide-induced tumor flare reaction
por: Suyama, Takahiro, et al.
Publicado: (2021)

The name counts: the case of 'congenital amegakaryocytic thrombocytopenia'
por: Balduini, Carlo L.
Publicado: (2022)

Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection
por: Ichimata, Shojiro, et al.
Publicado: (2017)

Danazol: An Effective Option in Acquired Amegakaryocytic Thrombocytopaenic Purpura
por: Mulroy, E., et al.
Publicado: (2015)

Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: The uncharted territory
por: Dragani, Matteo, et al.
Publicado: (2020)

Congenital Amegakaryocytic Thrombocytopenia: A Brief Review of the Literature
por: Al-Qahtani, Fatma S.
Publicado: (2010)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
por: Pecci, Alessandro, et al.
Publicado: (2017)

Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces HSPCs in mice
por: Nagai, Koki, et al.
Publicado: (2023)

Myelodysplastic Syndrome Presenting as Amegakaryocytic Thrombocytopenia in a Collodion Baby
por: Al Pakra, Mohammed, et al.
Publicado: (2015)

Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia
por: Tu, Xiaofang, et al.
Publicado: (2022)

Radiation‑induced pure red cell aplasia combined with acquired amegakaryocytic thrombocytopenia in a thymoma after rapid response to radiotherapy: A case report and literature review
por: Xue, Yinyin, et al.
Publicado: (2023)

Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up
por: Mirzania, Mehrzad, et al.
Publicado: (2014)

Durvalumab/elasomeran: Immune thrombocytopenia: case report
Publicado: (2022)

Massive hemoperitoneum from hemorrhagic corpus luteum in a patient with acquired amegakaryocytic thrombocytopenic purpura
por: Obi, Esther Ifeoma, et al.
Publicado: (2020)

PB2066: SYSTEMIC LUPUS ERYTHEMATOSUS-INDUCED AMEGAKARYOCYTIC THROMBOCYTOPENIA AND SUBSEQUENT APLASTIC ANEMIA
por: Seong, Gyuhee, et al.
Publicado: (2023)

Severe Clinical Course in a Patient with Congenital Amegakaryocytic Thrombocytopenia Due to a Missense Mutation of the c-MPL Gene
por: Ok Bozkaya, İkbal, et al.
Publicado: (2015)

PB1946: ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENA (AAMT), A SINGLE CENTER EXPERIENCE
por: Mohamed, S., et al.
Publicado: (2022)

Drug‐induced immune‐mediated thrombocytopenia secondary to durvalumab use
por: Dougherty, Sean C., et al.
Publicado: (2021)

Haploidentical Hematopoietic Stem Cell Transplantation in a 3-Year-Old Girl with Congenital Amegakaryocytic Thrombocytopenia: A Case Report
por: Wang, Sisi, et al.
Publicado: (2022)

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients
por: Germeshausen, Manuela, et al.
Publicado: (2020)

Real time PCR reconfirmed three novel clinical associations of parvovirus B19: Non-occlusive bowel gangrene, amegakaryocytic thrombocytopenia & myositis
por: Kishore, Janak
Publicado: (2015)

Defective binding of ETS1 and STAT4 due to a mutation in the promoter region of THPO as a novel mechanism of congenital amegakaryocytic thrombocytopenia
por: Capaci, Valeria, et al.
Publicado: (2022)

Immune‐mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non‐small cell lung cancer patient: A case report
por: Makiguchi, Tomonori, et al.
Publicado: (2021)

Good response with durvalumab after chemoradiotherapy for epidermal growth factor receptor exon 20 insertion adenocarcinoma: A case report
por: Matsuura, Shun, et al.
Publicado: (2020)

Retinal Vasculitis Secondary to Durvalumab
por: R. Andrade, Antonio, et al.
Publicado: (2020)

Acute Acquired Immune Thrombocytopenia After Cardiac Surgery: A Challenging Case
por: Auci, Elisabetta, et al.
Publicado: (2023)

Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab
por: Taima, Kageaki, et al.
Publicado: (2020)

Fatal limbic encephalitis as paraneoplastic neurological syndrome in a patient with lung adenocarcinoma positive for antiamphiphysin antibody after durvalumab treatment
por: Iwanaga, Yuto, et al.
Publicado: (2023)

Acquired Factor V Inhibitor Complicated with Immune Thrombocytopenia
por: Mima, Fuka, et al.
Publicado: (2021)

Durvalumab induced sarcoid‐like pulmonary lymphadenopathy
por: Sanderson, Emma, et al.
Publicado: (2020)

Durvalumab: Immune-related pneumonitis: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ldb36phs47lnl21a2sbrjtakjf